Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue. Viti V, Zanetta C, Capra R, Municchi A, et al. J Neurol 2024 Jul 11. doi: 10.1007/s00415-024-12553.

Read + Share

Amedeo Smart

Independent Medical Education

Viti V, Zanetta C, Capra R, Municchi A, et al. Ocrelizumab-associated enteritis in patients with multiple sclerosis: an emerging safety issue. J Neurol 2024 Jul 11. doi: 10.1007/s00415-024-12553.
PMID: 38992209